Trial Profile

A phase IIb study to evaluate SAL200 for Methicillin-resistant Staphylococcus aureus infections

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tonabacase (Primary)
Indications Methicillin-resistant Staphylococcus aureus infections
Focus Therapeutic Use

Most Recent Events

28 Sep 2021 According to a iNtRON Biotechnology media release, the company plans to file an IND application for a US Phase 2b clinical trial within second half of this year.
03 Dec 2018 New trial record
19 Nov 2018 According to a Roivant Sciences media release, the company plans to initiate Phase 2 clinical trial in 2019.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com